CRIS Current Research Information System

CAMPIERI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.533
AS - Asia 5.940
EU - Europa 5.636
AF - Africa 499
SA - Sud America 438
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 21.065
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.402
SG - Singapore 1.864
CN - Cina 1.440
VN - Vietnam 1.423
GB - Regno Unito 1.318
IT - Italia 867
SE - Svezia 828
DE - Germania 733
HK - Hong Kong 504
RU - Federazione Russa 345
BR - Brasile 323
UA - Ucraina 299
IN - India 294
IE - Irlanda 292
FR - Francia 254
NL - Olanda 142
TG - Togo 139
CI - Costa d'Avorio 127
ZA - Sudafrica 112
BG - Bulgaria 100
CH - Svizzera 95
FI - Finlandia 95
JO - Giordania 92
JP - Giappone 91
KR - Corea 86
EE - Estonia 84
SC - Seychelles 83
BE - Belgio 62
CA - Canada 57
AR - Argentina 53
HN - Honduras 36
ID - Indonesia 30
PL - Polonia 27
NG - Nigeria 23
ES - Italia 21
IR - Iran 21
GR - Grecia 18
MX - Messico 16
BZ - Belize 15
CL - Cile 15
EC - Ecuador 15
AU - Australia 14
BD - Bangladesh 14
UZ - Uzbekistan 12
AT - Austria 11
IQ - Iraq 11
PY - Paraguay 10
TR - Turchia 10
CO - Colombia 9
CZ - Repubblica Ceca 7
HR - Croazia 7
LT - Lituania 7
MY - Malesia 7
PT - Portogallo 7
RO - Romania 7
TW - Taiwan 7
AZ - Azerbaigian 5
PH - Filippine 5
PK - Pakistan 5
VE - Venezuela 5
BO - Bolivia 4
KE - Kenya 4
DK - Danimarca 3
EG - Egitto 3
IL - Israele 3
LB - Libano 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
JM - Giamaica 2
KZ - Kazakistan 2
MU - Mauritius 2
RS - Serbia 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
IS - Islanda 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
SN - Senegal 1
SO - Somalia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
Totale 21.064
Salva come PNG Salva come JPEG
Città #
Singapore 1.217
Southend 1.110
Ashburn 957
Chandler 806
Fairfield 763
Hong Kong 494
Santa Clara 468
Dong Ket 421
Woodbridge 411
Houston 351
Princeton 348
Seattle 332
Wilmington 329
Dublin 292
Ann Arbor 291
Cambridge 273
Beijing 268
Ho Chi Minh City 235
Boardman 186
Hefei 175
Hanoi 174
Jacksonville 165
Bologna 152
Lomé 139
Abidjan 127
Berlin 127
Nanjing 120
Westminster 114
Los Angeles 112
Padova 104
Sofia 96
New York 94
Amman 92
Milan 92
Helsinki 84
Bern 79
San Diego 75
Seoul 75
Buffalo 74
Tokyo 74
Shenyang 60
Frankfurt am Main 58
Turin 53
Dallas 52
Saint Petersburg 52
Phoenix 47
Changsha 45
Redondo Beach 45
Hebei 43
Jinan 42
Nanchang 41
Brussels 38
Mülheim 38
Guangzhou 36
Yubileyny 36
Bremen 34
Henderson 34
Medford 34
Redwood City 34
Munich 32
Falkenstein 29
Rome 29
Washington 29
Chicago 27
Centro 26
Saint Louis 26
Haiphong 25
Tianjin 25
London 24
Shanghai 24
São Paulo 24
Bengaluru 23
Da Nang 23
Dearborn 23
Olalla 23
Redmond 23
Jiaxing 22
Atlanta 21
Brierley Hill 21
Haikou 20
Mahé 19
Taizhou 19
Toronto 19
Montreal 18
Zhengzhou 18
Abeokuta 17
Ninh Bình 17
Norwalk 17
Falls Church 16
Florence 16
Nuremberg 16
Poplar 16
Belize City 15
Boston 15
Quận Bình Thạnh 15
Warsaw 15
Cervia 14
Hải Dương 14
Pune 14
Taiyuan 14
Totale 13.561
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 591
Ulcerative Colitis 316
Essential oils as intestinal microbiota regulators in models of mice induced colitis. 289
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 283
Acute granulomatous interstitial nephritis and ulcerative colitis: A case report and literature review 249
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 220
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 215
Adult attachment and early parental experiences in patients with Crohn’s Disease 212
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 207
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 206
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 205
Stress and brain functional changes in patients with Crohn's disease: A functional magnetic resonance imaging study 203
Antioxidant, anti-inflammatory, and microbial-modulating activities of essential oils: Implications in colonic pathophysiology 201
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 197
Infliximab in the treatment of Crohn's disease 196
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 196
Attachment and perceived stress in patients with ulcerative colitis, a case–control study 195
Attachment and quality of life in patients with inflammatory bowel disease 189
Medical treatment and management of severe ulcerative colitis 187
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 187
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 185
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 184
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 183
High-dose probiotics for the treatment of active pouchitis 183
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 182
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 182
Influence of steroid treatment's duration in patients with active Crohn's disease 181
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 179
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 179
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 179
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 176
Alessitimia e stress percepito in 323 pazienti affetti da IBD 173
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 173
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 173
Clinical course of microscopic colitis in a single-center cohort study 173
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 172
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 171
Attachment and mentalizing abilities in patients with inflammatory bowel disease 171
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 170
Management and treatment of distal ulcerative colitis 168
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 166
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review 165
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 164
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 164
Antibiotics and probiotics in treatment of inflammatory bowel disease 163
Oral budesonide in the treatment of chronic refractory pouchitis. 160
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 160
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 160
null 159
Review article: aminosalicylates for distal colitis 156
Management of inflammatory bowel disease: does rifaximin offer any promises 153
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 153
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 153
Which therapies are advisable in pouchitis? 151
Role of conventional therapies in the era of biological treatment in Crohn's disease. 151
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 150
Antimicrobials in the management of inflammatory bowel disease 150
Parental Bonding and Inflammatory Bowel Disease 150
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 149
The role of Budesonide-MMX in active ulcerative colitis. 149
MANAGEMENT OF POUCHITIS 149
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 148
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis 147
Sympathetic hyperactivity in patients with ulcerative colitis. 145
Randomized controlled trials in pouchitis 145
A new oral delivery system for 5-ASA: preliminary clinical findings for MMx 144
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 144
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 143
Problematic proctitis and distal colitis 143
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 142
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 141
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 140
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 139
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 139
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 139
Oral beclomethasone dipropionate in chronic refractory pouchitis 138
Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation 138
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 138
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells 137
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 136
The role of antibiotics and probiotics in pouchitis 133
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 133
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin 130
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. 130
The effects of probiotic bacteria on spontaneous contraction of isolated guinea-pig intestine 129
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. 129
Probiotic therapy to prevent pouchitis onset 129
Risk of permanent stoma in extensive Crohn's colitis: The impact of biological drugs 125
The safety of beclomethasone dipropionate in the treatment of ulcerative colitis 125
M1085 Use of Infliximab and Adalimumab in Refractory Pouchitis 123
TREATMENT OF PERIANAL CROHN'S DISEASE WITH COMBINED SURGICAL AND BIOLOGICAL THERAPY 121
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials 120
Ancient pathogen-driven adaptation triggers increased susceptibility to non-celiac wheat sensitivity in present-day European populations 119
RISK OF SHORT TERM POSTOPERATIVE COMPLICATIONS IN PATIENTS TREATED WITH AZATHIOPRINE FOR CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE 117
Probiotics and barrier function in colitis 115
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 113
ORAL BECLOMETHASONE DIPROPIONATE IN THE TREATMENT OF CHRONIC REFRACTORY POUCHITIS 111
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 111
Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue 109
p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis 109
Totale 16.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.618 0 0 0 0 0 142 101 200 194 192 81 708
2021/20222.895 307 68 172 138 213 106 65 124 262 228 806 406
2022/20233.471 379 509 198 413 198 294 82 199 666 81 229 223
2023/2024989 69 147 92 77 98 272 46 51 21 61 27 28
2024/20253.291 176 490 291 218 649 158 207 111 41 219 95 636
2025/20264.117 913 626 666 532 903 477 0 0 0 0 0 0
Totale 21.624